Friday, April 3, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

A conversation with Dr. Catherine London, opioid policy expert and a true fighter

There are victims and then there are leaders. Dr. London was supposed to be the former, but she has become the latter. After enduring years of erroneous claims made against her by the DEA and the Maine medical licensing board, she decided to take matters into her own hands by attending law school.

Now in her last year of law school, she intends on becoming a leader in opioid policy and medical jurisprudence.

To learn more about her research, please see the publication below:

https://wpsites.maine.edu/mlipa/2021/11/15/predicting-drug-diversion-the-use-of-data-analytics-in-prescription-drug-monitoring/

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!